JPRN-UMIN000030532已完成未知
The effect of anagliptin on blood glucose and serum lipids in Patients with type 2 diabetes mellitus - The effect of anagliptin on blood glucose and serum lipids in patients with type 2 diabetes mellitus
Japan Community Health care Organization, Yokohama Hodogaya Central Hospital0 个研究点目标入组 40 人开始时间: 2017年12月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Allergy for anagliptin. 2. Severe ketosis, diabetic coma severe infection, before operation, severe trauma 3. Severe renal dysfunction including hemodialysis or peritoneal dialysis (SCr:more than 1.5mg/dl ) 4. Pregnancy 5. Patients judged by the investigator to be ineligible for some other reason
研究者
相似试验
已完成
不适用
Study of the effect of anagliptin on glucose and lipid metabolism abnormality after the test meal loading.JPRN-UMIN000011424Kanazawa Medical University10
已完成
不适用
The effect of anagliptin on blood glucose and lipid levels in type 2 diabetes melliusType 2 diabetes mellitusJPRN-UMIN000012533Yokohama City University Medical Center100
已完成
不适用
Effect of anagliptin on plasma glucagon levels determined by LC-MS/MS in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000028293St. Marianna University School of Medicine24
已完成
4 期
Effects of sitagliptin and vildagliptin on glucose fluctuations in patients with type 2 diabetes -prospective open-label controlled studytype 2 diabetes mellitusJPRN-UMIN000005627Department of Medicine II, Hokkaido University Hospital40
尚未招募
不适用
Effects of sitaglyptin 100mg on glucose cotrol in patients with type2 diabetes compared with sitaglyptin 50mg with sulphonylurea or alpha-glucosidase inhibitortype2 diabetes mellitusJPRN-UMIN000005508Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University75